Cargando…

Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression

Rhabdomyosarcoma (RMS) is a soft tissue sarcoma, which may originate from impaired differentiation of mesenchymal stem cells (MSC). Expression of MET receptor is elevated in alveolar RMS subtype (ARMS) which is associated with worse prognosis, compared to embryonal RMS (ERMS). Forced differentiation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Skrzypek, Klaudia, Kusienicka, Anna, Szewczyk, Barbara, Adamus, Tomasz, Lukasiewicz, Ewa, Miekus, Katarzyna, Majka, Marcin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741613/ https://www.ncbi.nlm.nih.gov/pubmed/26384300

Ejemplares similares

SNAIL is a key regulator of alveolar rhabdomyosarcoma tumor growth and differentiation through repression of MYF5 and MYOD function
por: Skrzypek, Klaudia, et al.
Publicado: (2018)

The decreased metastatic potential of rhabdomyosarcoma cells obtained through MET receptor downregulation and the induction of differentiation
por: Miekus, K, et al.
Publicado: (2013)

Enhancement of myogenic differentiation and inhibition of rhabdomyosarcoma progression by miR-28-3p and miR-193a-5p regulated by SNAIL
por: Skrzypek, Klaudia, et al.
Publicado: (2021)

Myogenic Differentiation of iPS Cells Shows Different Efficiency in Simultaneous Comparison of Protocols
por: Ulman, Aleksandra, et al.
Publicado: (2021)

Impact of AMPK on cervical carcinoma progression and metastasis
por: Konieczny, Paweł, et al.
Publicado: (2023)

SNAIL Promotes Metastatic Behavior of Rhabdomyosarcoma by Increasing EZRIN and AKT Expression and Regulating MicroRNA Networks
por: Skrzypek, Klaudia, et al.
Publicado: (2020)

Progression and Differentiation of Alveolar Rhabdomyosarcoma Is Regulated by PAX7 Transcription Factor—Significance of Tumor Subclones
por: Skrzypek, Klaudia, et al.
Publicado: (2021)

Genome Editing of the SNAI1 Gene in Rhabdomyosarcoma: A Novel Model for Studies of Its Role
por: Ulman, Aleksandra, et al.
Publicado: (2020)

C-Met as a Key Factor Responsible for Sustaining Undifferentiated Phenotype and Therapy Resistance in Renal Carcinomas
por: Marona, Paulina, et al.
Publicado: (2019)

MET receptor is a potential therapeutic target in high grade cervical cancer
por: Miekus, Katarzyna, et al.
Publicado: (2015)

Interplay among SNAIL Transcription Factor, MicroRNAs, Long Non-Coding RNAs, and Circular RNAs in the Regulation of Tumor Growth and Metastasis
por: Skrzypek, Klaudia, et al.
Publicado: (2020)

Downregulation of the CXCR4 receptor inhibits cervical carcinoma metastatic behavior in vitro and in vivo
por: SEKUŁA, MAŁGORZATA, et al.
Publicado: (2014)

Myogenic regulatory transcription factors regulate growth in rhabdomyosarcoma
por: Tenente, Inês M, et al.
Publicado: (2017)

BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcoma
por: Laubscher, Dominik, et al.
Publicado: (2021)

SIX1 reprograms myogenic transcription factors to maintain the rhabdomyosarcoma undifferentiated state
por: Hsu, Jessica Y., et al.
Publicado: (2022)

Exon skipping in genes encoding lineage-defining myogenic transcription factors in rhabdomyosarcoma
por: Butler, Erin, et al.
Publicado: (2022)

A Natural Hepatocyte Growth Factor/Scatter Factor Autocrine Loop in Myoblast Cells and the Effect of the Constitutive Met Kinase Activation on Myogenic Differentiation
por: Anastasi, Sergio, et al.
Publicado: (1997)

Cancer-targeted IL-12 controls human rhabdomyosarcoma by senescence induction and myogenic differentiation
por: Schilbach, Karin, et al.
Publicado: (2015)

Differentiation-dependent chromosomal organization changes in normal myogenic cells are absent in rhabdomyosarcoma cells
por: Ibarra, Joe, et al.
Publicado: (2023)

Differentiation-dependent chromosomal organization changes in normal myogenic cells are absent in rhabdomyosarcoma cells
por: Ibarra, Joe, et al.
Publicado: (2023)

PAX3-FOXO1 dictates myogenic reprogramming and rhabdomyosarcoma identity in endothelial progenitors
por: Searcy, Madeline B., et al.
Publicado: (2023)

MET Inhibition Sensitizes Rhabdomyosarcoma Cells to NOTCH Signaling Suppression
por: Perrone, Clara, et al.
Publicado: (2022)

Resistance to tyrosine kinase inhibitors promotes renal cancer progression through MCPIP1 tumor-suppressor downregulation and c-Met activation
por: Marona, Paulina, et al.
Publicado: (2022)

Use of 3D Organoids as a Model to Study Idiopathic Form of Parkinson’s Disease
por: Chlebanowska, Paula, et al.
Publicado: (2020)

Induction of myogenic differentiation in human rhabdomyosarcoma cells by ionising radiation, N,N-dimethylformamide and their combination.
por: Nicoletti, G., et al.
Publicado: (1992)

PROX1 transcription factor controls rhabdomyosarcoma growth, stemness, myogenic properties and therapeutic targets
por: Gizaw, Nebeyu Yosef, et al.
Publicado: (2022)

Dickkopf-1 Inhibition Reactivates Wnt/β-Catenin Signaling in Rhabdomyosarcoma, Induces Myogenic Markers In Vitro and Impairs Tumor Cell Survival In Vivo
por: Giralt, Irina, et al.
Publicado: (2021)

Restoration of p16(INK4A) protein induces myogenic differentiation in RD rhabdomyosarcoma cells
por: Urashima, M, et al.
Publicado: (1999)

JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells
por: Walters, Zoë S, et al.
Publicado: (2013)

Reductive stress impairs myogenic differentiation
por: Rajasekaran, Namakkal S., et al.
Publicado: (2020)

Camptothecin exhibits topoisomerase1-independent KMT1A suppression and myogenic differentiation in alveolar rhabdomyosarcoma cells
por: Wolff, David W., et al.
Publicado: (2018)

SGPL1(321) mutation: one main trigger for invasiveness of pediatric alveolar rhabdomyosarcoma
por: Adamus, Anna, et al.
Publicado: (2019)

The zebrafish HGF receptor met controls migration of myogenic progenitor cells in appendicular development
por: Nord, Hanna, et al.
Publicado: (2019)

Multifunctional protein APPL2 contributes to survival of human glioma cells
por: Pyrzynska, Beata, et al.
Publicado: (2012)

SPRY2 is a novel MET interactor that regulates metastatic potential and differentiation in rhabdomyosarcoma
por: Saini, Masum, et al.
Publicado: (2018)

Origin of the Induced Pluripotent Stem Cells Affects Their Differentiation into Dopaminergic Neurons
por: Chlebanowska, Paula, et al.
Publicado: (2020)

Retinoic acid induces myogenin synthesis and myogenic differentiation in the rat rhabdomyosarcoma cell line BA-Han-1C
Publicado: (1992)

Modulation of Myogenic Differentiation in a Human Rhabdomyosarcoma Cell Line by a New Derivative of 5‐Fluorouracil (QF‐3602)
por: Marchal, Juan Antonio, et al.
Publicado: (2000)

Rhabdomyosarcoma and Wilms tumors contain a subpopulation of noggin producing, myogenic cells immunoreactive for lens beaded filament proteins
por: Gerhart, Jacquelyn, et al.
Publicado: (2019)

Upregulation of miR181a/miR212 Improves Myogenic Commitment in Murine Fusion-Negative Rhabdomyosarcoma
por: Pozzo, Enrico, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9vo1dpljevuv3ikp93k7c9q4eb